150 related articles for article (PubMed ID: 28547128)
21. Posterior fossa and spinal gangliogliomas form two distinct clinicopathologic and molecular subgroups.
Gupta K; Orisme W; Harreld JH; Qaddoumi I; Dalton JD; Punchihewa C; Collins-Underwood R; Robertson T; Tatevossian RG; Ellison DW
Acta Neuropathol Commun; 2014 Feb; 2():18. PubMed ID: 24529209
[TBL] [Abstract][Full Text] [Related]
22. BRAF mutation and CDKN2A deletion define a clinically distinct subgroup of childhood secondary high-grade glioma.
Mistry M; Zhukova N; Merico D; Rakopoulos P; Krishnatry R; Shago M; Stavropoulos J; Alon N; Pole JD; Ray PN; Navickiene V; Mangerel J; Remke M; Buczkowicz P; Ramaswamy V; Guerreiro Stucklin A; Li M; Young EJ; Zhang C; Castelo-Branco P; Bakry D; Laughlin S; Shlien A; Chan J; Ligon KL; Rutka JT; Dirks PB; Taylor MD; Greenberg M; Malkin D; Huang A; Bouffet E; Hawkins CE; Tabori U
J Clin Oncol; 2015 Mar; 33(9):1015-22. PubMed ID: 25667294
[TBL] [Abstract][Full Text] [Related]
23. Rosetted glioneuronal tumour of the spine: clinical, histological and cytogenetic data.
Rickert CH; Jasper M; Sepehrnia A; Jeibmann A
Acta Neuropathol; 2006 Aug; 112(2):231-3. PubMed ID: 16816942
[No Abstract] [Full Text] [Related]
24. BRAF and CDKN2A mutations in secondary high-grade glioma.
Boughton B
Lancet Oncol; 2015 May; 16(5):e201. PubMed ID: 25818616
[No Abstract] [Full Text] [Related]
25. Spinal cord astroblastoma with an EWSR1-BEND2 fusion classified as a high-grade neuroepithelial tumour with MN1 alteration.
Yamasaki K; Nakano Y; Nobusawa S; Okuhiro Y; Fukushima H; Inoue T; Murakami C; Hirato J; Kunihiro N; Matsusaka Y; Honda-Kitahara M; Ozawa T; Shiraishi K; Kohno T; Ichimura K; Hara J
Neuropathol Appl Neurobiol; 2020 Feb; 46(2):190-193. PubMed ID: 31863478
[No Abstract] [Full Text] [Related]
26. Unusual radiological and histological presentation of a diffuse leptomeningeal glioneuronal tumor (DLGNT) in a 13-year-old girl.
Tiwari N; Tamrazi B; Robison N; Krieger M; Ji J; Tian D
Childs Nerv Syst; 2019 Sep; 35(9):1609-1614. PubMed ID: 30770994
[TBL] [Abstract][Full Text] [Related]
27. BRAF-Mutated Pleomorphic Xanthoastrocytoma of the Spinal Cord with Eventual Anaplastic Transformation.
Hong CS; Wang JL; Dornbos D; Joehlin-Price A; Elder JB
World Neurosurg; 2017 Feb; 98():871.e9-871.e15. PubMed ID: 27956254
[TBL] [Abstract][Full Text] [Related]
28. Unusual high-grade features in pediatric diffuse leptomeningeal glioneuronal tumor: comparison with a typical low-grade example.
Schwetye KE; Kansagra AP; McEachern J; Schmidt RE; Gauvain K; Dahiya S
Hum Pathol; 2017 Dec; 70():105-112. PubMed ID: 28652147
[TBL] [Abstract][Full Text] [Related]
29. Cervical cord tumor in two haemophilic brothers.
Blaauw G; Schenk VW
J Neurol Sci; 1971 Dec; 14(4):409-16. PubMed ID: 5125755
[No Abstract] [Full Text] [Related]
30. A comprehensive analysis identifies BRAF hotspot mutations associated with gliomas with peculiar epithelial morphology.
Hatae R; Hata N; Suzuki SO; Yoshimoto K; Kuga D; Murata H; Akagi Y; Sangatsuda Y; Iwaki T; Mizoguchi M; Iihara K
Neuropathology; 2017 Jun; 37(3):191-199. PubMed ID: 27792249
[TBL] [Abstract][Full Text] [Related]
31. Leptomeningeal spread of intramedullary spinal cord tumors. Report of three cases.
Bell WO; Packer RJ; Seigel KR; Rorke LB; Sutton LN; Bruce DA; Schut L
J Neurosurg; 1988 Aug; 69(2):295-300. PubMed ID: 3392575
[TBL] [Abstract][Full Text] [Related]
32. Platelet-derived growth factor receptor (PDGFR) expression in primary spinal cord gliomas.
Ellis JA; Canoll P; McCormick PC; Feldstein NA; Anderson RC; Angevine PD; Kaiser MG; McCormick PC; Bruce JN; Ogden AT
J Neurooncol; 2012 Jan; 106(2):235-42. PubMed ID: 21789698
[TBL] [Abstract][Full Text] [Related]
33. Cytogenetic findings in a rare pediatric mixed glioneuronal tumor and review of the literature.
Coccé MC; Lubieniecki F; Bartuluchi M; Gallego MS
Childs Nerv Syst; 2009 Nov; 25(11):1485-90. PubMed ID: 19387654
[TBL] [Abstract][Full Text] [Related]
34. Expression of CD133 as a Putative Prognostic Biomarker to Predict Intracranial Dissemination of Primary Spinal Cord Astrocytoma.
Inoue T; Endo T; Nakamura T; Shibahara I; Endo H; Tominaga T
World Neurosurg; 2018 Feb; 110():e715-e726. PubMed ID: 29180077
[TBL] [Abstract][Full Text] [Related]
35. BRAF V600E mutation in epilepsy-associated glioneuronal tumors: Prevalence and correlation with clinical features in a Chinese population.
Zhang YX; Shen CH; Guo Y; Zheng Y; Zhu JM; Ding Y; Tang YL; Wang S; Ding MP
Seizure; 2017 Feb; 45():102-106. PubMed ID: 27984807
[TBL] [Abstract][Full Text] [Related]
36. Rosetted glioneuronal tumor of the spine with overtly anaplastic histological features.
Scholz M; Hoischen A; Radlwimmer B; Weber RG; Harders A; Reifenberger G; Riemenschneider MJ
Acta Neuropathol; 2009 May; 117(5):591-3. PubMed ID: 19266208
[No Abstract] [Full Text] [Related]
37. Intramedullary gangliogliomas: histopathologic and molecular features of 25 cases.
Gessi M; Dörner E; Dreschmann V; Antonelli M; Waha A; Giangaspero F; Gnekow A; Pietsch T
Hum Pathol; 2016 Mar; 49():107-13. PubMed ID: 26826417
[TBL] [Abstract][Full Text] [Related]
38. Spinal cord ependymomas and myxopapillary ependymomas in the first 2 decades of life: a clinicopathological and immunohistochemical characterization of 19 cases.
Stephen JH; Sievert AJ; Madsen PJ; Judkins AR; Resnick AC; Storm PB; Rushing EJ; Santi M
J Neurosurg Pediatr; 2012 Jun; 9(6):646-53. PubMed ID: 22656257
[TBL] [Abstract][Full Text] [Related]
39. Analysis of IDH1-R132 mutation, BRAF V600 mutation and KIAA1549-BRAF fusion transcript status in central nervous system tumors supports pediatric tumor classification.
Gierke M; Sperveslage J; Schwab D; Beschorner R; Ebinger M; Schuhmann MU; Schittenhelm J
J Cancer Res Clin Oncol; 2016 Jan; 142(1):89-100. PubMed ID: 26115961
[TBL] [Abstract][Full Text] [Related]
40. ZFTA-YAP1 fusion-positive ependymoma can occur in the spinal cord: Letter to the editor.
Lim KY; Lee KH; Phi JH; Yun H; Won JK; Choi SH; Park SH
Brain Pathol; 2022 Jan; 32(1):e13020. PubMed ID: 34506076
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
